Blockade of transamination, where glutamine is converted to TCA elements, was shown to be more effective at suppressing breast cancer cells overexpressing YAP/TAZ, suggesting that YAP-promoting glutamine dependence is a crucial metabolic adaptation strategy in breast cancer [34]. Here, WWTR1 is linked to breast cancer.